Archives
-
Anti-HMGB1 Rabbit Monoclonal Antibody: Technical Workflow Gu
2026-06-17
The Anti-HMGB1 Rabbit Monoclonal Antibody (SKU MA3057) enables specific and reproducible detection of HMGB1 protein in human, mouse, and rat samples using Western blot, immunohistochemistry, and flow cytometry. It is intended exclusively for research workflows that require high specificity in chromatin protein detection, and is not suitable for diagnostic or therapeutic applications.
-
Exosomal SNORD52 Drives M2 Macrophage Polarization via JAK2/
2026-06-16
This study uncovers how hepatoma cell-derived exosomal SNORD52 promotes M2 macrophage polarization by activating the JAK2/STAT6 pathway. The findings illuminate a novel non-coding RNA-mediated mechanism in hepatocellular carcinoma microenvironment remodeling, suggesting new research targets for cancer immunopathology.
-
γH2AX DNA Damage Detection Kit: Precision for DNA Damage Bio
2026-06-16
The γH2AX DNA Damage Detection Kit (Mouse mAb/Red) delivers high-sensitivity detection of DNA double-strand breaks, setting a new standard for apoptosis, genotoxicity, and radiotherapy research. Its rapid, multiplexed workflow and robust troubleshooting support empower users to achieve reproducible, publication-grade results—even in demanding applications such as FLASH-RT and immune microenvironment profiling.
-
Cy3 Goat Anti-Rabbit IgG (H+L) Antibody: Practical Use Guide
2026-06-15
The Cy3 Goat Anti-Rabbit IgG (H+L) Antibody addresses sensitive detection of rabbit primary antibodies in immunofluorescence, IHC, and related workflows where high specificity and signal amplification are essential. It should be used in protocols requiring robust fluorescent secondary antibody performance but is not suitable for diagnostic or medical use. Researchers must follow handling and storage guidelines to maintain dye integrity and experimental reliability.
-
Degarelix Acetate: Precision GnRH Antagonism for Hormone Stu
2026-06-15
Degarelix acetate offers rapid, selective GnRH receptor antagonism, enabling robust in vitro and in vivo workflows for hormone secretion inhibition and prostate cancer research. This guide details experimental setups, troubleshooting strategies, and actionable insights from recent structure-activity studies to maximize reproducibility and data clarity.
-
FGF14 GAA Repeat Expansions in SCA27B: Insights from a Polis
2026-06-14
This systematic review and family case report clarify the genetic and clinical landscape of spinocerebellar ataxia 27B (SCA27B), attributing its cause to GAA repeat expansions in FGF14. The study applies long-range PCR and Nanopore sequencing, providing new data on phenotypic presentation in a Polish family and synthesizing patterns across 815 cases.
-
Strategic Fluorescence: Cy3 IgG Antibody in Translational Im
2026-06-13
Explore how the Cy3 Goat Anti-Human IgG (H+L) Antibody advances translational research by bridging mechanistic insight with clinical relevance. This article uniquely integrates competitive positioning, evidence from orthopoxvirus antibody research, and actionable protocol guidance for next-generation immunoassays.
-
Cyclophilin A’s Critical Role in Calcineurin Inhibitor Speci
2026-06-12
This study demonstrates that cyclophilin A deficiency confers resistance to cyclosporine-induced immunosuppression, establishing CypA as the primary mediator of cyclosporine’s effect on T-cell responses. These findings clarify the molecular selectivity of calcineurin inhibitors and inform the design of precise immune modulation models.
-
G007-LK Tankyrase 1/2 Inhibitor: Precision for Wnt/β-Catenin
2026-06-12
G007-LK delivers unparalleled specificity for tankyrase inhibition in Wnt/β-catenin and Hippo pathway research, supporting advanced APC mutation colorectal cancer and hepatocellular carcinoma models. This guide unpacks optimized workflows, real-world troubleshooting, and actionable protocol parameters, positioning G007-LK as a go-to tool for pathway-targeted cancer research.
-
Muscle-Derived BDNF and MMP-Mediated Synaptic Assembly at NM
2026-06-11
This study reveals how spatially localized, muscle-generated BDNF—regulated by activity and proteolytic processing—directs the initial assembly of postsynaptic apparatus at vertebrate neuromuscular junctions (NMJs). The findings clarify the intersection of vesicular trafficking, calcium signaling, and extracellular matrix metalloproteinase (MMP) activity in orchestrating acetylcholine receptor (AChR) cluster formation, with methodological implications for both developmental neuroscience and in vitro MMP inhibition assays.
-
iRGD-Red Blood Cell Membrane Nanocarriers Enhance PDT in Neu
2026-06-11
Wu et al. present a targeted drug delivery system using iRGD-modified red blood cell (RBC) membrane vesicles for improved photodynamic therapy (PDT) in neuroblastoma. This biomimetic platform shows substantially enhanced drug encapsulation, tumor penetration, and therapeutic efficacy, highlighting a promising avenue for precision oncology applications.
-
γH2AX DNA Damage Detection Kit: A Gateway to Functional DNA
2026-06-10
Discover how the γH2AX DNA Damage Detection Kit enables functional DNA damage and repair research beyond conventional DSB detection. This article integrates mechanistic advances and the latest radioimmunotherapy breakthroughs for researchers seeking unparalleled assay relevance.
-
Bispecific Antibodies Targeting MPXV: Enhanced Orthopoxvirus
2026-06-10
This study characterizes monoclonal antibodies against the major immunogens M1R and B6R of mpox virus (MPXV), mapping their epitopes and functional profiles. Through innovative bispecific antibody engineering, the authors demonstrate improved antiviral efficacy in vitro and in vivo, highlighting a promising strategy for broad-spectrum orthopoxvirus therapeutics.
-
HyperFluor™ 594 Goat Anti-Rabbit IgG: Precision in Immunodet
2026-06-09
The HyperFluor™ 594 Goat Anti-Rabbit IgG (H+L) Antibody empowers researchers with high-specificity detection and multiplexing capabilities across ICC, IHC, flow cytometry, and ELISA. By leveraging its robust fluorophore and optimized protocols, laboratories can accelerate discovery and overcome typical immunofluorescence hurdles.
-
Glioma-Derived Soluble PD-L1 Suppresses CD8+ T Cells via Wnt
2026-06-09
This study reveals that glioma cells secrete soluble PD-L1 (sPD-L1) through Wnt/β-catenin signaling, which directly impairs CD8+ T cell function and correlates with tumor burden. The findings highlight sPD-L1 as a promising prognostic biomarker and therapeutic target in glioma immunotherapy.